Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Okamoto

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Cancer Research|December 17, 2010
Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutationsKunio Okamoto, Isamu Okamoto, Wataru Okamoto, et al.
Clinical Journal of Gastroenterology|February 22, 2023
A case of unresectable intrahepatic cholangiocarcinoma with a germline BRCA1 mutationYumiko Yamashita, Yasutaka Ishii, Masahiro Serikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia]Taro Ueda, Masashi Namba, Tadashi Senoo, et al.
Molecular Cancer Therapeutics|June 26, 2012
Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplificationWataru Okamoto, Isamu Okamoto, Tokuzo Arao, et al.
Clinical Journal of Gastroenterology|December 27, 2022
Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutationKenjiro Okada, Kenichiro Uemura, Wataru Okamoto, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Journal of Surgical Case Reports|May 24, 2021
Radical surgery for anal canal neuroendocrine carcinoma with pagetoid spread: a case reportSotaro Fukuhara, Masanori Yoshimitsu, Takuya Yano, et al.
Journal of Cancer Survivorship : Research and Practice|February 15, 2025
Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort studyKazuya Saita, Kazuaki Tanabe, Yoichi Hamai, et al.
Cancer Science|October 7, 2009
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplificationTakeshi Yoshida, Isamu Okamoto, Wataru Okamoto, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|February 22, 2022
Hemoglobin-albumin clusters as an artificial O<sub>2</sub> carrier: Physicochemical properties and resuscitation from hemorrhagic shock in ratsWataru Okamoto, Mai Hasegawa, Tomone Usui, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Cancer Research|December 17, 2010
Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutationsKunio Okamoto, Isamu Okamoto, Wataru Okamoto, et al.
Clinical Journal of Gastroenterology|February 22, 2023
A case of unresectable intrahepatic cholangiocarcinoma with a germline BRCA1 mutationYumiko Yamashita, Yasutaka Ishii, Masahiro Serikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia]Taro Ueda, Masashi Namba, Tadashi Senoo, et al.
Molecular Cancer Therapeutics|June 26, 2012
Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplificationWataru Okamoto, Isamu Okamoto, Tokuzo Arao, et al.
Clinical Journal of Gastroenterology|December 27, 2022
Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutationKenjiro Okada, Kenichiro Uemura, Wataru Okamoto, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Journal of Surgical Case Reports|May 24, 2021
Radical surgery for anal canal neuroendocrine carcinoma with pagetoid spread: a case reportSotaro Fukuhara, Masanori Yoshimitsu, Takuya Yano, et al.
Journal of Cancer Survivorship : Research and Practice|February 15, 2025
Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort studyKazuya Saita, Kazuaki Tanabe, Yoichi Hamai, et al.
Cancer Science|October 7, 2009
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplificationTakeshi Yoshida, Isamu Okamoto, Wataru Okamoto, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|February 22, 2022
Hemoglobin-albumin clusters as an artificial O<sub>2</sub> carrier: Physicochemical properties and resuscitation from hemorrhagic shock in ratsWataru Okamoto, Mai Hasegawa, Tomone Usui, et al.
Pageof 10